US 8476263
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
granted A61KA61K31/5383A61K31/675
Quick answer
US patent 8476263 (Prodrugs of 2,4-pyrimidinediamine compounds and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/5383, A61K31/675, A61P, A61P1/04